MOLLY DAY: Open Payments
NPI 1063029197 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 13 payments from 8 companies in 2025. Trend: 2023 $384 · 2024 $301 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $174 |
| Endo USA, Inc. | 4 | $156 |
| Dendreon Pharmaceuticals LLC | 1 | $108 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $50 |
| IMMUNITYBIO, INC. | 1 | $26 |
| TOLMAR, INC. | 1 | $20 |
| Photocure Inc | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: XIAFLEX, EMRELIS, PROVENGE, PYLARIFY, LUPRON DEPOT, ANKTIVA, BOTOX, JATENZO.
Industry payments across LA — which companies pay providers there.
